Trial registration for public trust: Making the case for medical devices

Journal of General Internal Medicine

Volumn 23, Issue 1 SUPPL., 2008, Pages 64-68

  Sim, Ida ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Medical device industry; Public trust; Trial registration policies

Indexed keywords

BIOTECHNOLOGY; CLINICAL TRIAL; DRUG ELUTING STENT; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; LAW ENFORCEMENT; MARKETING; MEDICAL INSTRUMENTATION; MEDICAL RESEARCH; PATIENT CARE; REGISTER; RESEARCH ETHICS; REVIEW; WORLD HEALTH ORGANIZATION;

CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DEVICE APPROVAL; DRUG INDUSTRY; EQUIPMENT AND SUPPLIES; HUMANS; INTERDISCIPLINARY COMMUNICATION; PATIENT SELECTION; POLICY MAKING; TRUST; UNITED STATES;

EID: 37348999895     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0463-2     Document Type: Review

References (27)

1. People of the State of New York vs GlaxoSmithKline. Filed June 2, 2004.
2. Curfman GD, Morrissey S, Drazen JM. Expression of concern: Bombardier et al., Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520-8.
3. N Engl J Med 2005;353(26):2813-4.
4. DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the international committee of medical journal editors. JAMA. 2004;292(11):1363-4.
5. AdvaMed Response to the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Request for Comments on Delayed Disclosure. March 31, 2006.
6. Popp RL, Lorell BH, Stone GW, Laskey W, Smith JJ, Kaplan AV. An outline for public registration of clinical trials evaluating medical devices. J Am Coll Cardiol. 2006;47(8):1518-21.
7. Profitless prosperity. The Economist, April 20, 2006.
8. Cutler D. The demise of the blockbuster? N Engl J Med. 2007;356(13):1292-3.
9. Maisel WH. Medical device regulation: an introduction for the practicing physician. Ann Intern Med. 2004;140(4):296-302.
10. Califf RM. Evaluation of diagnostic imaging technologies and therapeutics devices: better information for better decisions: proceedings of a multidisciplinary workshop. Am Heart J. 2006;152(1):50-8.
11. Rennie D. Trial registration: a great idea switches from ignored to irresistible. JAMA. 2004;292(11):1359-62.
12. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290(4):516-23.
13. Krleza-Jeric K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ. 2005;330(7497):956-8.
14. World Health Organization. International Clinical Trials Registry Platform. Available at: http://www.who.int/ictrp/. Accessed March 29, 2007.
15. World Health Organization. International Clinical Trials Registry Platform Glossary. Available at: http://www.who.int/ictrp/glossary/en/index. html. Accessed March 29, 2007.
16. IFPMA Comments to ICTRP Consultation on Delayed Disclosure. January 25, 2006. Available at: http://www.who.int/ictrp/3005_IFPMA_25Jan06.pdf. Accessed March 29, 2007.
17. Sim I, Chan AW, Gülmezoglu AM, Evans T, Pang T. Clinical trial registration: transparency is the watchword. Lancet. 2006;367(9523):1631-3.
18. Laine C, Horton R, Deangelis CD, et al. Clinical trial registration: Looking back and moving ahead. N Engl J Med. 2007;356(26):2734-6.
19. Lassman S. RE: PhRMA comments on international clinical trials registry platform (ICTRP) disclosure timing. January 25, 2006. Available at: http://www.who.int/ictrp/3010_PhRMA_25Jan06.pdf. Accessed March 29, 2007.
20. World Medical Association. Declaration of Helsinki. 9 Oct 2004. Available at: http://www.wma.net/e/policy/b3.htm. Accessed March 29, 2007.
21. Nuremberg Code. Trials of war criminals before the Nuremberg military tribunals under control council law No. 10. In: U.S. Government Printing Office; Washington, D.C; 1949:181-2.
22. Palmisano S. The information puzzle. Newsweek, December 2, 2005.
23. Enhancing Drug Safety and Innovation Act, H.R. 1561, 110th Congress, 1st Session (2007).
24. Enhancing Drug Safety and Innovation Act, S. 484, 110th Congress, 1st Session (2007).
25. Derbis J, Toigo T, Woods J, Evelyn B, Banks D. FDAMA Section 113: Information program on clinical trials for serious or life threatening diseases: update on implementation. In: 9th Annual FDA Science Forum. Washington, D.C; 2003.
26. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;353(26):2779-87.
27. Patsopoulos NA, Ioannidis JP, Analatos AA. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006;332(7549):1061-4.